These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11260866)

  • 1. Identification of a recurrent BRCA1 mutation in German breast-cancer and/or ovarian-cancer families.
    Hofmann W; Jandrig B; Classen E; Nestle-Kraemling C; Chang-Claude J; Scherneck S
    J Cancer Res Clin Oncol; 2001; 127(3):200-2. PubMed ID: 11260866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
    Meindl A;
    Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.
    Sarantaus L; Auranen A; Nevanlinna H
    Int J Oncol; 2001 Apr; 18(4):831-5. PubMed ID: 11251181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland.
    Mullen P; Miller WR; Mackay J; Fitzpatrick DR; Langdon SP; Warner JP
    Br J Cancer; 1997; 75(9):1377-80. PubMed ID: 9155062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
    Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
    JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.
    Zhang B; Fackenthal JD; Niu Q; Huo D; Sveen WE; DeMarco T; Adebamowo CA; Ogundiran T; Olopade OI
    Fam Cancer; 2009; 8(1):15-22. PubMed ID: 18679828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
    Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of BRCA1 mutation 5382insC in German breast cancer patients.
    Backe J; Hofferbert S; Skawran B; Dörk T; Stuhrmann M; Karstens JH; Untch M; Meindl A; Burgemeister R; Chang-Claude J; Weber BH
    Gynecol Oncol; 1999 Mar; 72(3):402-6. PubMed ID: 10053113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
    Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC
    JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
    Unger MA; Nathanson KL; Calzone K; Antin-Ozerkis D; Shih HA; Martin AM; Lenoir GM; Mazoyer S; Weber BL
    Am J Hum Genet; 2000 Oct; 67(4):841-50. PubMed ID: 10978226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families.
    Jara L; Ampuero S; Santibáñez E; Seccia L; Rodríguez J; Lay-Son MB; Ojeda JM; Reyes JM; Blanco R
    Biol Res; 2004; 37(3):469-81. PubMed ID: 15515971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families.
    Reeves MD; Yawitch TM; van der Merwe NC; van den Berg HJ; Dreyer G; van Rensburg EJ
    Int J Cancer; 2004 Jul; 110(5):677-82. PubMed ID: 15146556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
    Caligo MA; Ghimenti C; Cipollini G; Ricci S; Brunetti I; Marchetti V; Olsen R; Neuhausen S; Shattuck-Eidens D; Conte PF; Skolnick MH; Bevilacqua G
    Oncogene; 1996 Oct; 13(7):1483-8. PubMed ID: 8875986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
    Verhoog LC; van den Ouweland AM; Berns E; van Veghel-Plandsoen MM; van Staveren IL; Wagner A; Bartels CC; Tilanus-Linthorst MM; Devilee P; Seynaeve C; Halley DJ; Niermeijer MF; Klijn JG; Meijers-Heijboer H
    Eur J Cancer; 2001 Nov; 37(16):2082-90. PubMed ID: 11597388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
    Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
    J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
    Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
    Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 mutations in German breast-cancer families.
    Jandrig B; Grade K; Seitz S; Waindzoch B; Müller M; Bender E; Nothnagel A; Rohde K; Schlag PM; Kath R; Höffken K; Scherneck S
    Int J Cancer; 1996 Oct; 68(2):188-92. PubMed ID: 8900426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM; Kataja V; Pirskanen M; Arffman A; Ristonmaa U; Vahteristo P; Ryynänen M; Heinonen S; Kosma VM; Mannermaa A
    Clin Genet; 2007 Oct; 72(4):311-20. PubMed ID: 17850627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.